IMNN: Updated OVATION 2 Data Shows 14.7-Month Improvement in OS Compared to SoC

142 Views26 Mar 2026 00:00

Issuer-paid

On March 25, 2026, Imunon, Inc. (IMNN) announced updated overall survival (OS) data from the OVATION 2 trial that showed a now 14.7-month increase...

What is covered in the Full Insight:

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 7-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream

IMNN: Updated OVATION 2 Data Shows 14.7-Month Improvement in OS Compared to SoC
26 Mar 2026